Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2007

View Archived Issues

Minocycline has positive effects on atherosclerotic plaques

J591 targets metastatic sites in patients with advanced solid tumors

InterMune focuses on programs for pirfenidone and ITMN-191

Terameprocol found effective in patients with oral leukoplakia

Phase I/II studies to investigate nab-docetaxel for prostate and breast cancers

Inex anticipates 2007 milestones

IL-21 benefits mice with melanoma

Transition Therapeutics to acquire NeuroMedix

ASKA and Yakult Honsha sign agreement for soblidotin

Arpida completes enrollment in iclaprim phase III program

EVT-302 for smoking cessation begins clinical testing

Enrollment completed in phase Ib cancer study of bavituximab

Merck & Co. licenses Japanese rights to Cubicin

Topigen and Novagali collaborate on allergic ocular diseases and allergic rhinitis

ProAlgaZyme to be studied in metabolic syndrome patients

Clomet studied in phase I for solid tumors

Amgen discontinues Vectibix treatment in PACCE trial

Trexima amended response accepted for review

CDC adopts ACIP's recommendations on use of Gardasil

UCB to begin new study on Cimzia in Crohn's disease

Bioavailability of cetrorelix in Japanese subjects similar to that in non-Japanese

Ambrisentan MAA validated by EMEA

Bosentan recommended for E.U. approval to reduce digital ulcers

CHMP recommends approval of Remicade for pediatric Crohn's disease

MK-0974 enters phase III program, NDA expected for 2009

Recent patents report novel therapeutic agents for the treatment of respiratory disorders

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...